|
|
||||||||
Institute for Immunology, Johannes Gutenberg University, Mainz, Germany
IL-4 was found to be the essential differentiation factor for Th2
cells and simultaneously to be a potent inhibitor of Th1 development
that is induced by IFN-
and IL-12. Furthermore, it was demonstrated
that TGF-ß can also inhibit Th1 development. In this work, we
demonstrate that polyclonal activation of
Mel-14highCD4+ T cells by immobilized
anti-
ßTCR mAb together with a mixture of IL-4 and TGF-ß can
lead to the development of both Th1 and Th2 cells, depending on the
concentration of these cytokines. Additional experiments revealed that
Th1 induction by a combination of IL-4 and TGF-ß depends on the
presence of endogenous IFN-
, and that this alternative Th1
development is further enhanced by IL-12, but is not dependent on this
cytokine. Moreover, naive OVA323339-specific Th cells
that were stimulated by APCs and OVA323339 peptide
differentiated toward Th1 cells after priming in the presence of IL-4
in combination with TGF-ß. Hence, this finding confirmed the results
obtained by polyclonal activation of naive CD4+ Th cells
and implicates that this alternative Th1 development may also occur in
vivo under the influence of TGF-ß and IL-4 independently of the
Th1-promoting effect of IL-12.
This article has been cited by other articles:
![]() |
E. Linos, T. Raine, A. Alonso, and D. Michaud Atopy and Risk of Brain Tumors: A Meta-analysis J Natl Cancer Inst, October 17, 2007; 99(20): 1544 - 1550. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Walther, J. Woodruff, F. Edele, D. Jeffries, J. E. Tongren, E. King, L. Andrews, P. Bejon, S. C. Gilbert, J. B. De Souza, et al. Innate Immune Responses to Human Malaria: Heterogeneous Cytokine Responses to Blood-Stage Plasmodium falciparum Correlate with Parasitological and Clinical Outcomes J. Immunol., October 15, 2006; 177(8): 5736 - 5745. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Eguchi, N. Kuwashima, M. Hatano, F. Nishimura, J. E. Dusak, W. J. Storkus, and H. Okada IL-4-Transfected Tumor Cell Vaccines Activate Tumor-Infiltrating Dendritic Cells and Promote Type-1 Immunity J. Immunol., June 1, 2005; 174(11): 7194 - 7201. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Lucas, N. McNeil, E. Hilgenfeld, B. Choudhury, S.-J. Kim, M. A. Eckhaus, T. Ried, and R. E. Gress Transforming Growth Factor-{beta} Pathway Serves as a Primary Tumor Suppressor in CD8+ T Cell Tumorigenesis Cancer Res., September 15, 2004; 64(18): 6524 - 6529. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Bream, R. E. Curiel, C.-R. Yu, C. E. Egwuagu, M. J. Grusby, T. M. Aune, and H. A. Young IL-4 synergistically enhances both IL-2- and IL-12-induced IFN-{gamma} expression in murine NK cells Blood, July 1, 2003; 102(1): 207 - 214. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Smeltz, J. Chen, R. Ehrhardt, and E. M. Shevach Role of IFN-{gamma} in Th1 Differentiation: IFN-{gamma} Regulates IL-18R{alpha} Expression by Preventing the Negative Effects of IL-4 and by Inducing/Maintaining IL-12 Receptor {beta}2 Expression J. Immunol., June 15, 2002; 168(12): 6165 - 6172. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Letterio, T. Lehrnbecher, G. Pollack, T. J. Walsh, and S. J. Chanock Invasive Candidiasis Stimulates Hepatocyte and Monocyte Production of Active Transforming Growth Factor {beta} Infect. Immun., August 1, 2001; 69(8): 5115 - 5120. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Fukao, D. M. Frucht, G. Yap, M. Gadina, J. J. O'Shea, and S. Koyasu Inducible Expression of Stat4 in Dendritic Cells and Macrophages and Its Critical Role in Innate and Adaptive Immune Responses J. Immunol., April 1, 2001; 166(7): 4446 - 4455. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, E. Rosloniec, M. I. Goral, M. Boothby, and J. Chen Redirection of T Cell Effector Function In Vivo and Enhanced Collagen-Induced Arthritis Mediated by an IL-2R{{beta}}/IL-4R{{alpha}} Chimeric Cytokine Receptor Transgene J. Immunol., March 15, 2001; 166(6): 4163 - 4169. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Oh and M. C. Eichelberger Polarization of Allogeneic T-Cell Responses by Influenza Virus-Infected Dendritic Cells J. Virol., September 1, 2000; 74(17): 7738 - 7744. [Abstract] [Full Text] |
||||
![]() |
K. M. Giezeman-Smits, H. Okada, C. S. Brissette-Storkus, L. A. Villa, J. Attanucci, M. T. Lotze, I. F. Pollack, M. E. Bozik, and W. H. Chambers Cytokine Gene Therapy of Gliomas: Induction of Reactive CD4+ T Cells by Interleukin-4-transfected 9L Gliosarcoma Is Essential for Protective Immunity Cancer Res., May 1, 2000; 60(9): 2449 - 2457. [Abstract] [Full Text] |
||||
![]() |
T. Kato and H. Nariuchi Polarization of Naive CD4+ T Cells Toward the Th1 Subset by CTLA-4 Costimulation J. Immunol., April 1, 2000; 164(7): 3554 - 3562. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Fukao, S. Matsuda, and S. Koyasu Synergistic Effects of IL-4 and IL-18 on IL-12-Dependent IFN-{gamma} Production by Dendritic Cells J. Immunol., January 1, 2000; 164(1): 64 - 71. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |